Century Therapeutics Inc (IPSC)
Earnings
Annual and quarterly EPS data presented alongside analyst estimates, earnings surprises, and historical growth statistics. The side-by-side view of reported versus estimated EPS — combined with surprise percentage and report timing — allows investors to assess whether a company consistently beats, meets, or misses market expectations, and how that track record has evolved across full economic cycles.
Earnings annual
Fiscal date endingReported EPS
Dec 31, 2019
-0.5138
Dec 31, 2020
-0.9517
Dec 31, 2021
-5.04
Dec 31, 2022
-3.82
Dec 31, 2023
-2.22
Dec 31, 2024
-1.63
Dec 31, 2025
-0.06
Mar 31, 2026
-0.11
Jun 30, 2026
-0.28
Calculation
Growth rate
7.31%
Average
-1.625
Maximum
Dec 31, 2025
-0.06
Minimum
Dec 31, 2021
-5.04
Median
Dec 31, 2020
-0.9517
Earnings quarterly
| Fiscal date ending | Dec 31, 2019 |
| Reported date | Mar 30, 2020 |
| Report time | PRE_MARKET |
| Reported EPS | -0.5138 |
| Estimated EPS | 0 |
| Surprise | -0.5138 |
| Surprise (%) | % |
| Fiscal date ending | Dec 31, 2020 |
| Reported date | Mar 30, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | -0.9517 |
| Estimated EPS | 0 |
| Surprise | -0.9517 |
| Surprise (%) | % |
| Fiscal date ending | Mar 31, 2021 |
| Reported date | Jun 21, 2021 |
| Report time | POST_MARKET |
| Reported EPS | -2.39 |
| Estimated EPS | -0.44 |
| Surprise | -1.95 |
| Surprise (%) | -443.1818% |
| Fiscal date ending | Jun 30, 2021 |
| Reported date | Aug 12, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | -1.93 |
| Estimated EPS | -0.38 |
| Surprise | -1.55 |
| Surprise (%) | -407.8947% |
| Fiscal date ending | Sep 30, 2021 |
| Reported date | Nov 10, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | -0.48 |
| Estimated EPS | -0.42 |
| Surprise | -0.06 |
| Surprise (%) | -14.2857% |
| Fiscal date ending | Dec 31, 2021 |
| Reported date | Mar 17, 2022 |
| Report time | PRE_MARKET |
| Reported EPS | -0.24 |
| Estimated EPS | -0.48 |
| Surprise | 0.24 |
| Surprise (%) | 50% |
| Fiscal date ending | Mar 31, 2022 |
| Reported date | May 16, 2022 |
| Report time | PRE_MARKET |
| Reported EPS | -0.48 |
| Estimated EPS | -0.54 |
| Surprise | 0.06 |
| Surprise (%) | 11.1111% |
| Fiscal date ending | Jun 30, 2022 |
| Reported date | Aug 11, 2022 |
| Report time | PRE_MARKET |
| Reported EPS | -0.54 |
| Estimated EPS | -0.5 |
| Surprise | -0.04 |
| Surprise (%) | -8% |
| Fiscal date ending | Sep 30, 2022 |
| Reported date | Nov 10, 2022 |
| Report time | PRE_MARKET |
| Reported EPS | -0.53 |
| Estimated EPS | -0.6 |
| Surprise | 0.07 |
| Surprise (%) | 11.6667% |
| Fiscal date ending | Dec 31, 2022 |
| Reported date | Mar 16, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -2.27 |
| Estimated EPS | -0.59 |
| Surprise | -1.68 |
| Surprise (%) | -284.7458% |
| Fiscal date ending | Mar 31, 2023 |
| Reported date | May 11, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.53 |
| Estimated EPS | -0.52 |
| Surprise | -0.01 |
| Surprise (%) | -1.9231% |
| Fiscal date ending | Jun 30, 2023 |
| Reported date | Aug 9, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.49 |
| Estimated EPS | -0.54 |
| Surprise | 0.05 |
| Surprise (%) | 9.2593% |
| Fiscal date ending | Sep 30, 2023 |
| Reported date | Nov 9, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.55 |
| Estimated EPS | -0.49 |
| Surprise | -0.06 |
| Surprise (%) | -12.2449% |
| Fiscal date ending | Dec 31, 2023 |
| Reported date | Mar 14, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.65 |
| Estimated EPS | -0.55 |
| Surprise | -0.1 |
| Surprise (%) | -18.1818% |
| Fiscal date ending | Mar 31, 2024 |
| Reported date | May 9, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.45 |
| Estimated EPS | -0.45 |
| Surprise | 0 |
| Surprise (%) | 0% |
| Fiscal date ending | Jun 30, 2024 |
| Reported date | Aug 8, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.38 |
| Estimated EPS | -0.5 |
| Surprise | 0.12 |
| Surprise (%) | 24% |
| Fiscal date ending | Sep 30, 2024 |
| Reported date | Nov 5, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.37 |
| Estimated EPS | -0.45 |
| Surprise | 0.08 |
| Surprise (%) | 17.7778% |
| Fiscal date ending | Dec 31, 2024 |
| Reported date | Mar 19, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -0.43 |
| Estimated EPS | -0.45 |
| Surprise | 0.02 |
| Surprise (%) | 4.4444% |
| Fiscal date ending | Mar 31, 2025 |
| Reported date | May 15, 2025 |
| Report time | POST_MARKET |
| Reported EPS | 0.89 |
| Estimated EPS | -0.31 |
| Surprise | 1.2 |
| Surprise (%) | 387.0968% |
| Fiscal date ending | Jun 30, 2025 |
| Reported date | Aug 14, 2025 |
| Report time | POST_MARKET |
| Reported EPS | -0.38 |
| Estimated EPS | -0.37 |
| Surprise | -0.01 |
| Surprise (%) | -2.7027% |
| Fiscal date ending | Sep 30, 2025 |
| Reported date | Nov 13, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -0.32 |
| Estimated EPS | -0.38 |
| Surprise | 0.06 |
| Surprise (%) | 15.7895% |
| Fiscal date ending | Dec 31, 2025 |
| Reported date | Mar 12, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | -0.25 |
| Estimated EPS | -0.2975 |
| Surprise | 0.0475 |
| Surprise (%) | 15.9664% |
| Fiscal date ending | Mar 31, 2026 |
| Reported date | May 13, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | -0.11 |
| Estimated EPS | -0.17 |
| Surprise | 0.06 |
| Surprise (%) | 35.2941% |
| Fiscal date ending | Jun 30, 2026 |
| Reported date | Aug 12, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | -0.17 |
| Estimated EPS | -0.11 |
| Surprise | -0.06 |
| Surprise (%) | -54.5455% |
Calculation
Growth rate
4.70%
Average
-0.605
Maximum
Mar 31, 2025
0.89
Minimum
Mar 31, 2021
-2.39
Median
Sep 30, 2021
-0.48